Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Sanofi in closure of $11.6 billion hemophilia specialist buy
February 23, 2018 Off

Sanofi in closure of $11.6 billion hemophilia specialist buy

By Dino Mustafić

Sanofi’s waiting period to complete the purchase of Bioverativ has came to an end, and will thus expand its hemophilia and other…

Gilead’s Executive VP, commerctial operations, to retire
February 23, 2018 Off

Gilead’s Executive VP, commerctial operations, to retire

By Dino Mustafić

Gilead Sciences will begin a search for new Commercial Operation Executive Vice President in the coming weeks’s, as its current…

FDA could extend Allergan, Medicines360’s contraceptive hormone-releasing system Liletta duration
February 22, 2018 Off

FDA could extend Allergan, Medicines360’s contraceptive hormone-releasing system Liletta duration

By Dino Mustafić

Allergan and Medicines360, a global nonprofit women’s health pharmaceutical company dedicated to expanding access to quality medicines, have announced that…

Mylan’s combination HIV treatment available in developing countries as a first-line regimen for people being treated for HIV/AIDS
February 22, 2018 Off

Mylan’s combination HIV treatment available in developing countries as a first-line regimen for people being treated for HIV/AIDS

By Dino Mustafić

World’s largest HIV/AIDS drug-maker Mylan has received tentative approval for combination HIV treatment DTG/FTC/TAF under FDA’s PEPFAR program, the company…

Novo Nordisk wants to submit its new type 2 diabetes tablet in 2019, first phase trial hits aim
February 22, 2018 Off

Novo Nordisk wants to submit its new type 2 diabetes tablet in 2019, first phase trial hits aim

By Dino Mustafić

Novo Nordisk has completed the first phase 3a trial, PIONEER 1, with oral semaglutide, for treating type 2 diabetes in…

Novartis’s Ultibro Breezhaler can reduce lung hyperinflation and improve cardiac function
February 22, 2018 Off

Novartis’s Ultibro Breezhaler can reduce lung hyperinflation and improve cardiac function

By Dino Mustafić

Novartis has announced the publication of the CLAIM study in the Lancet Respiratory Medicine, which demonstrated that treatment once-daily Ultibro…

Vertex aims for triple combination to patients with cystic fibrosis
February 22, 2018 Off

Vertex aims for triple combination to patients with cystic fibrosis

By Dino Mustafić

Vertex Pharmaceuticals wants to submit a New Drug Application in the USA, so it will soon give the final test…

BASF introduces Hepaxa in the U.S. for non-alcoholic fatty liver disease patients
February 22, 2018 Off

BASF introduces Hepaxa in the U.S. for non-alcoholic fatty liver disease patients

By Dino Mustafić

BASF Corporation is introducing  Hepaxa, a product that can help tens of millions of patients manage Non-Alcoholic Fatty Liver Disease…

WuXi STA, Regulus in microRNA development and manufacturing collaboration
February 22, 2018 Off

WuXi STA, Regulus in microRNA development and manufacturing collaboration

By Dino Mustafić

STA Pharmaceutical, a WuXi AppTec group company has entered into a deal with Regulus Therapeutics, an oligonucleotide synthesis collaboration agreement…

Celgene gets clearance for $9Billion Juno acquisition, strengthens its hematology global reach
February 21, 2018 Off

Celgene gets clearance for $9Billion Juno acquisition, strengthens its hematology global reach

By Dino Mustafić

Celgene expects the transaction for Juno Therapeutics shares, to close in the first quarter of 2018. The company has said Wednesday…

Posts pagination

Previous 1 … 3,402 3,403 3,404 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine